The Fibrodysplasia Ossificans Progressiva Learning Center
First Do No Harm: Realizing Timely Diagnosis and Treatment for Patients with Fibrodysplasia Ossificans Progressiva.
This Learning Center is a freely accessible educational platform for healthcare providers who see patients with FOP. Our goal is to ensure that you – the practicing clinician – have access to the most accurate, up-to-date information for the treatment of patients with FOP.
We encourage you to share this educational resource with your colleagues and your healthcare team.
Course Director
Courses
Prevent the Consequences of Incorrect/Delayed Diagnosis
Credit Available: 0.5 AMA PRA Category 1 Credit(s)™
This activity reviews the impact of erroneous diagnosis on patient outcomes, as well as explore methods, including clinical evaluation and genetic testing, to facilitate a timely and accurate diagnosis of FOP.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Understanding the Hallmarks and History of Patients with FOP
Credit Available: 0.5 AMA PRA Category 1 Credit(s)™
This activity reviews the unique clinical presentations of FOP and addresses the clinical of delayed disease identification and diagnosis on patients.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Improving Outcomes With Appropriate Clinical Management: Do No Harm, but Can We Help?
Credit Available: 0.5 AMA PRA Category 1 Credit(s)™
This activity will explore safe and efficacious strategies to manage FOP with supportive treatments. It will also review the mechanism of action, safety, efficacy, and potential clinical utility of emerging disease-targeting treatments.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Enhancing Early Recognition and Management of FOP: Strategies for the Pediatric Clinician
Credit Available: 1.5 AMA PRA Category 1 Credit(s)™
This activity presents FOP disease background and strategies to facilitate early recognition and diagnosis, as well as the most recent clinical trial data of emerging targeted treatment strategies.
[Accreditation has expired. For informational purposes only.]
Course Faculty
Robert J. Pignolo, MD, PHD | Edna Mancilla, MD | Matthew Drake, MD, PhD | Mona Al Mukaddam, MD, MS